The incidence and prognostic significance of additional chromosome restructuring in acute promyelocytic leukemia

Gematologiya i Transfusiologiya

Volumn 52, Issue 3, 2007, Pages 27-32

  Olshanskaya, Yu V ^a   Gutorova, D S ^a   Shuravina, E N ^a   Demidova, I A ^a   Udovichenko, A I ^a   Kulikov, S M ^a   Misyurin, A V ^a   Parovichnikova, E N ^a   Domracheva, E V ^a   Danilcheva, E S ^a   Savchenko, V G ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Acute promyelocyte leukemia; Additional chromosome restructuring; Fluorescent in situ hybridization; t(15; 17) translocation

Indexed keywords

EID: 34547844402     PISSN: 02345730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chambon P. A decade of molecular biology of retinoic acid receptors // FASEB J. -1996. -Vol. 10. -P. 940-954.
2. Grignani F., De Matteis S., Nervi C. et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia // Nature. -1998. - Vol. 391. - P. 815-818.
3. Wang Z., Chen Z., Huang W. et al. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA) // Blood Cells. - 1993. - Vol. 19. - P. 633-641.
4. Degos L., Dombert H., Chomienne C. et al. All-transretinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia // Blood. -1995. -Vol. 85. - P. 2643-2648.
5. Grimwade D., Walker H., Oliver F. et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial // Blood. - 1998. - Vol. 92. - P. 2322-2333.
6. Russian source
7. Russian source
8. Larson R. A., Kondo K., Vardiman J. W. Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia // Am. J. Med. -1984. -Vol. 76. -P. 827-841.
9. Berger R., Le Coniat M., Derre J. et al. Cytogenetic studies in acute promyelocytic leukemia: a survey of secondary chromosomal abnormalities // Genes Chromosomes Cancer. - 1991. - Vol. 3. - P. 332-337.
10. Schoch C., Haase D., Haferlach T. et al. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients // Br. J. Haematol. - 1996. - Vol. 94. - P. 493-500.
11. Slack J. L., Arthur D. C., Lawrence D. et al. Secondary cytogenetic changes in acute promyelocytic leukemia - prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study // J. Clin. Oncol. - 1997. - Vol. 15. -P. 1786-1795.
12. Hernandez J. M., Martin G., Gutierrez N. C. et al. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA // Haematologica. - 2001. -Vol. 86. - P. 807-813.
13. Burnett A. K., Grimwade D., Solomon E. et al. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial // Blood. - 1999. - Vol. 93. -P. 4131-4143.
14. De Botton S., Chevret S., Sanz M. et al. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial // Br. J. Haematol. -2000. -Vol. 111. - P. 801-806.
15. Hiorns L. R., Swansbury G. J., Mehta J. et al. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia // Br. J. Haematol. -1997. - Vol. 96. - P. 314-321.
16. Russian source
17. Russian source
18. Seabright M. A rapid banding technique for human chromosomes // Lancet. -1971. -Vol. 2. - P. 71-72.
19. An International System for Human Cytogenetic Nomenclature / Ed. F. S. Mitelman - Basel: Karger AG; 1995.
20. van Dongen J. J., Macintyre E. A., Gabert J. A. et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-I Concerted Action: investigation of minimal residual disease in acute leukemia // Leukemia. -1999. - Vol. 13. - P. 1901-1928.
21. Sessarego M., Fugazza G., Balleari E. et al. High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study //Cancer Genet. Cytogenet. - 1997. - Vol. 97. - P. 161-164.
22. Alcalay M., Zangrilli D., Fagioli M. et al. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia // Proc. Natl. Acad. Sci. USA. - 1992. - Vol. 89. - P. 4840-4844.
23. Grimwade D., Howe K., Langabeer S. et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M. R. C. ATRA trial. M. R. C. Adult Leukaemia Working Party // Br. J. Haematol. - 1996. - Vol. 94. - P. 557-573.
24. Borrow J., Goddard A. D., Gibbons B. et al. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts // Br. J. Haematol. - 1992. - Vol. 82. - P. 529-540.
25. Li Y. P., Andersen J., Zelent A. et al. RAR alphal/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study // Blood. - 1997. - Vol. 90. - P. 306-312.
26. Fukutani H., Nase T., Ohno R. et al. Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) // Leukemia. -1995. - Vol. 9 - P. 1478-1482.
27. Grisolano J. L., Wesselschmidt R. L., Pelicci P. G. et al. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences // Blood. - 1997. - Vol. 89. - P. 376-387.
28. Brown D., Kogan S., Lagasse E. et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia // Proc. Natl. Acad. Sci. USA. - 1997. - Vol. 94. -P. 2551-2556.
29. He L. Z., Tribioli C., Rrvi R. et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice // Proc. Nati. Acad. Sci. USA. - 1997. - Vol. 94. - P. 5302-5307.
30. Pollock J. L., Westervelt P., Kurichety A. K. et al. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia // Proc. Natl. Acad. Sci. USA. - 1999. -Vol. 96. - P. 15103-15108.
31. Zimonjic D. B., Pollock J. L., Westervelt P. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice // Proc. Natl. Acad. Sci. USA. -2000. - Vol. 97. - P. 13306-13311.
32. Le Beau M. M., Davis E. M., Patel B. et al. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia // Blood. -2003. - Vol. 102. - P. 1072-1074.
33. Virtaneva K., Wright F. A., Tanner S. M. et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics // Proc. Natl. Acad. Sci. USA. -2001. - Vol. 98. - P. 1124-1129.